Literature DB >> 15083242

Bacteremic Streptococcus bovis infections at a university hospital, 1992-2001.

Shio-Shin Jean1, Lee-Jene Teng, Po-Ren Hsueh, Shen-Wu Ho, Kwen-Tay Luh.   

Abstract

BACKGROUND AND
PURPOSE: The association of Streptococcus bovis biotypes with types of clinical infection and underlying malignancies has rarely been reported in Taiwan. The aim of this study was to characterize the clinical features and microbiological characteristics of patients with S. bovis bacteremia.
METHODS: From January 1992 to December 2001, 62 patients with S. bovis bacteremia were treated at National Taiwan University Hospital. Their demographic characteristics, clinical features, results of imaging studies, pathological findings, and laboratory data were retrospectively analyzed. Antimicrobial susceptibilities were determined using the agar dilution method and biotypes were determined using the API 20 Strep system.
RESULTS: The majority of cases (76%) occurred during the 1996-1997 and 1999-2000 periods. Thirty five patients were male, and the mean age of the 62 patients was 61 years. Underlying diseases included malignancies (40%), cardiac diseases (27%), diabetes mellitus (24%), and liver cirrhosis (21%). Fifty two percent (n = 32) of patients presented with primary bacteremia and 24% (15) with definite or possible infective endocarditis. Thirteen percent (8) presented with hepatobiliary infections (acute cholecystitis and biliary tract infection). Ten patients (16%) had polymicrobial bacteremia. All of the concomitant pathogen(s) were Gram-negative rods, among which Escherichia coli predominated. The mortality rate on day 30 of illness was 21%. High Acute Physiology and Chronic Health Evaluation (APACHE) II score on the day of positive blood culture was associated with high mortality. Among the 19 patients (31%) who underwent colonoscopy, 9 (47%) had colonic lesions (tubular adenomas or carcinomas). Of the 26 patients (41%) who underwent echocardiography, 14 (54%) had vegetation in the valves. Of the 47 S. bovis isolates examined for biotypes, 37 (79%) were biotype II (29 of biotype II/2 and 8 of biotype II/1) and 10 (21%) were biotype I. The majority of isolates causing primary bacteremia (92%), hepatobiliary infections (100%) and primary bacterial peritonitis (100%) were biotype II, while 67% of isolates associated with infective endocarditis were biotype I. All isolates were susceptible to penicillin.
CONCLUSIONS: Infective endocarditis should be highly suspected in patients with bacteremia due to S. bovis biotype I. Investigations for intra-abdominal foci other than the colon should be undertaken in patients with bacteremia caused by S. bovis biotype II. Due to the increasing number of S. bovis bacteremia patients at the hospital and unknown origins of about 50% of bacteremia cases, the need for colonoscopy and echocardiography in each case and biotyping of each blood isolate should be emphasized.

Entities:  

Mesh:

Year:  2004        PMID: 15083242

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  10 in total

1.  Streptococcus bovis endophthalmitis: a unique presentation of colon cancer.

Authors:  Wissam Bleibel; Karl D'Silva; Ali Elhorr; Samer Bleibel; Upandra Dhanjal
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

2.  Correlation between Streptococcus bovis bacteremia and density of cows in Galicia, northwest of Spain.

Authors:  J Corredoira; E Miguez; L M Mateo; R Fernández-Rodriguez; J F García-Rodriguez; A Peréz-Gonzalez; A Sanjurjo; M V Pulian; R Rabuñal
Journal:  Infection       Date:  2018-11-29       Impact factor: 3.553

3.  Streptococcus bovis-related cholecystitis.

Authors:  Eoin McCarthy Deering; Zlatko Muravec; Constantino Fiuza Castineira; Gerry O'Donoghue
Journal:  BMJ Case Rep       Date:  2013-04-18

4.  Is colonoscopy necessary in cases of infection by Streptococcus bovis biotype II?

Authors:  J C Corredoira; M P Alonso; M J García-País; R Rabuñal; F García-Garrote; L López-Roses; A Lancho; A Coira; J Pita; D Velasco; M J López-Álvarez; H Tjalsma; J Varela
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-11       Impact factor: 3.267

5.  Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis.

Authors:  J Corredoira; M P Alonso; A Coira; E Casariego; C Arias; D Alonso; J Pita; A Rodriguez; M J López; J Varela
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-09       Impact factor: 3.267

6.  Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8.

Authors:  Ahmed S Abdulamir; Rand R Hafidh; Fatimah Abu Bakar
Journal:  Mol Cancer       Date:  2010-09-17       Impact factor: 27.401

7.  Sequencing and comparative genome analysis of two pathogenic Streptococcus gallolyticus subspecies: genome plasticity, adaptation and virulence.

Authors:  I-Hsuan Lin; Tze-Tze Liu; Yu-Ting Teng; Hui-Lun Wu; Yen-Ming Liu; Keh-Ming Wu; Chuan-Hsiung Chang; Ming-Ta Hsu
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

8.  Gut microbiota, inflammation and colorectal cancer.

Authors:  Jun Sun; Ikuko Kato
Journal:  Genes Dis       Date:  2016-04-13

9.  Streptococcus bovis Bacteremia in Neonates in a Predominantly Hispanic Population.

Authors:  Alicia Alvarez; Yi Jia; Cesar J Garcia; Eduardo D Rosas-Blum; Darius Boman; Marc J Zuckerman
Journal:  Front Pediatr       Date:  2015-10-30       Impact factor: 3.418

Review 10.  Bacterial and Parasitic Pathogens as Risk Factors for Cancers in the Gastrointestinal Tract: A Review of Current Epidemiological Knowledge.

Authors:  Janneke W Duijster; Eelco Franz; Jacques Neefjes; Lapo Mughini-Gras
Journal:  Front Microbiol       Date:  2021-12-08       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.